Successful COVID-19 elimination after an alpha variant outbreak in a "safe travel zone"
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:44 |
|---|---|
| Enthalten in: |
Travel medicine and infectious disease - 44(2021) vom: 15. Nov., Seite 102202 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Moury, Pierre-Henri [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 09.12.2021 Date Revised 21.12.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.tmaid.2021.102202 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM333057341 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM333057341 | ||
| 003 | DE-627 | ||
| 005 | 20231225220843.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.tmaid.2021.102202 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1110.xml |
| 035 | |a (DE-627)NLM333057341 | ||
| 035 | |a (NLM)34767909 | ||
| 035 | |a (PII)S1477-8939(21)00243-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Moury, Pierre-Henri |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Successful COVID-19 elimination after an alpha variant outbreak in a "safe travel zone" |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 09.12.2021 | ||
| 500 | |a Date Revised 21.12.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 700 | 1 | |a Gourinat, Ann-Claire |e verfasserin |4 aut | |
| 700 | 1 | |a Riou, Olivier |e verfasserin |4 aut | |
| 700 | 1 | |a Laumond, Sylvie |e verfasserin |4 aut | |
| 700 | 1 | |a Dupont-Rouzeyrol, Myrielle |e verfasserin |4 aut | |
| 700 | 1 | |a Cazorla, Cécile |e verfasserin |4 aut | |
| 700 | 1 | |a Mangeas, Morgan |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Travel medicine and infectious disease |d 2003 |g 44(2021) vom: 15. Nov., Seite 102202 |w (DE-627)NLM16457655X |x 1873-0442 |7 nnns |
| 773 | 1 | 8 | |g volume:44 |g year:2021 |g day:15 |g month:11 |g pages:102202 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.tmaid.2021.102202 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 44 |j 2021 |b 15 |c 11 |h 102202 | ||